Preparation and route: Injectable versus oral forms differ in bioavailability and stability
This multi-pathway approach explains both the peptides remarkable healing effects across different tissue types and the complexity of predicting its behavior in various biological contexts
Reduced insulin sensitivity, with increases in fasting blood glucose and HbA1c relative to placebo over 12 months in the same controlled trial, a concern for anyone with existing metabolic risk
Personalized care produces the best results
NEW COAs JUST LANDED 99% purity across every GLP-1 compoundIndependently lab-tested by Analiza Bialek European testingThird-party verified identity & purity every compound, every timeThe real deal
The patient profile that benefits most at our clinic looks like this: Soft tissue injury that has stalled: The patient has completed physical therapy, has no surgical indication, but is still symptomatic at 8 to 12 weeks